癌症中的V-ATPase:机制性见解和治疗潜力
Tingting Chen1, Xiaotan Lin2, Shuo Lu3
1School of Basic Medicine, Guangdong Medical University, DongGuan, China. jkf_ctt@163.com.
Cell communication and signaling : CCS
|December 20, 2024
概括
空腔型H+-ATPase (V-ATPase) 对于细胞pH平衡至关重要. 在癌症中,其增强的活性促进瘤生长,转移和耐药性,从而呈现出新的治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 真空类型的H+-ATPase (V-ATPase) 对于维持细胞内pH平衡和细胞功能至关重要.
- 失调的V-ATPase活性与各种生理过程有关,包括癌症的进展.
研究的目的:
- 审查癌细胞中V-ATPase的结构,功能和调节.
- 探索V-ATPase在瘤微环境调节,代谢调节和耐药性的作用.
- 确定V-ATPase作为癌症治疗的潜在治疗标.
主要方法:
- 本综述综合了关于V-ATPase的现有研究.
- 对V-ATPase的结构域 (V1和V0) 和质子机制的分析.
- 在癌症代谢中检查与mTORC1和AMPK的V-ATPase相互作用.
主要成果:
- 癌细胞中增强的V-ATPase活性与癌细胞的增殖,转移和入侵有关.
- V-ATPase调节瘤微环境的pH值,影响瘤的生长.
- V-ATPase 与mTORC1和AMPK相互作用,影响癌细胞代谢和耐药性.
- 在非正规的自中V-ATPase的作用提供了新的治疗途径.
结论:
- V-ATPase是癌症进展和耐药性的关键因素.
- 针对V-ATPase及其调节途径提供了有前途的治疗策略.
- 需要对瘤微环境中的V-ATPase机制进行进一步的研究,以获得临床转化.
相关概念视频
ATP Driven Pumps III: V-type Pumps
3.6K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.6K
ATP Synthase: Mechanism
13.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.9K
ATP Driven Pumps I: An Overview
7.9K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
7.9K
Electron Transport Chain: Complex I and II
11.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


